Cargando…
A randomized, controlled trial of triple antiviral therapy as initial treatment of chronic hepatitis C in HIV-infected patients()
BACKGROUND/AIMS: Interferon and ribavirin combination therapy for chronic hepatitis C induces a low response rate in human immunodeficiency virus (HIV) infected patients. To assess the impact of intensification of interferon administration and of the addition of amantadine on the efficacy and safety...
Autores principales: | Puoti, Massimo, Zanini, Barbara, Quinzan, Gian Paolo, Ravasio, Laura, Paraninfo, Giuseppe, Santantonio, Teresa, Rollo, Adriano, Artioli, Stefania, Maggiolo, Franco, Zaltron, Serena, MASTER HIV/HCV Co-infection study group, Raise, Enzo, Mignani, Ermenegildo, Resta, Francesco, Verucchi, Gabriella, Pastore, Giuseppe, Suter, Fredy, Carosi, Giampiero |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Association for the Study of the Liver. Published by Elsevier Ireland Ltd.
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7126192/ https://www.ncbi.nlm.nih.gov/pubmed/15288482 http://dx.doi.org/10.1016/j.jhep.2004.04.016 |
Ejemplares similares
-
Increasing Clinical Virulence in Two Decades of the Italian HIV Epidemic
por: Müller, Viktor, et al.
Publicado: (2009) -
Opto-Microfluidic Integration of the Bradford Protein Assay in Lithium Niobate Lab-on-a-Chip
por: Zanini, Leonardo, et al.
Publicado: (2022) -
Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agents
por: Perico, Norberto, et al.
Publicado: (2023) -
076 Risk of severe COVID-19 associated with immune-modifying drugs: data from PsoProtect and Global Rheumatology Alliance registries
por: Group, P Study, et al.
Publicado: (2022) -
Ctf2 design report: The CLIC Test Facility - CTF2 A two-beam test accelerator for linear collider studies The CLIC Study Group
por: CLIC Study Group
Publicado: (1996)